The Endpoints Slack interview: Zavain Dar on starting a new VC, trusting the process with the 76ers, and Apple's VR future

13 Feb 2024
About a decade ago, the front office of the Philadelphia 76ers attempted a radically new way of running a professional basketball team, bringing the “moneyball” approach to the game. Zavain Dar — an investor at Lux Capital — took on an advisor side gig using his love of basketball and data. The “Trust the Process” mantra turned the team into contenders. Dar, 35, is now betting a similar story will play out in the drug industry with data and AI. He left Lux to start his own fund, Dimension Capital, in 2022 alongside Nan Li and Adam Goulburn. The trio raised $350 million for its first fund to invest in the convergence of tech and biotech.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.